window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Patient Access

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Terumo BCT expands access to rare disease therapies across Latin America

    Terumo Blood and Cell Technologies has announced regulatory approvals for [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Opinion & Events,Pharmaceuticals and therapeutics

    Terumo BCT and PwC Belgium join forces to break barriers in access to advanced cell and gene therapies

    Terumo Blood and Cell Technologies (Terumo BCT), a medical technology [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics

    Pharmaceuticals and therapeutics: Lilly to raise drug prices in Europe as it cuts US patient costs

    Lilly has voiced strong support for the US administration’s goal [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Clinical trials: TransCelerate and FDA explore pragmatic trial designs to broaden patient access

    TransCelerate BioPharma and the US Food and Drug Administration (FDA) [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Digital & Data,Manufacturing & Supply Chain

    Unlocking collaboration: How data sharing and digital innovation are shaping the future of cell and gene therapy manufacturing

    The case for smarter collaboration in CGT manufacturing  As the [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory

    UK experts urge Government to appoint Minister for cell and gene therapies

    Commission sets out 25 policy recommendations to unlock access and [...]

    May 5, 2026
  • Manufacturing & Supply Chain,Opinion & Events

    Women in Pharma: Jenny Gattari on mentorship, manufacturing and making a difference

    Purpose, precision and progress: Jenny's advice on building a career that delivers. With more than 30 years of cross-functional experience spanning manufacturing, R&D, supply chain and commercial strategy, Jenny Gattari brings a rare depth of insight to her role as Global Business Development Lead at Pfizer CentreOne.

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    NICE backs mirikizumab for treatment-resistant Crohn’s disease

    The National Institute for Health and Care Excellence (NICE) has [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Digital shift aims to fix long-term gaps in cell and gene therapy trials

    Medable unveils a patient-first remote model to support 15-year safety [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    START and OneOncology expand access to early phase cancer trials in US communities

    A new partnership will bring early phase clinical trials closer [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development
  • Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Opinion & Events, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top